Loading...
XTSX
WBE
Market cap3mUSD
Jul 07, Last price  
0.13CAD
Name

Westbond Enterprises Corp

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.50
EPS
Div Yield, %
Shrs. gr., 5y
0.74%
Rev. gr., 5y
-4.09%
Revenues
9m
-16.86%
5,652,2706,259,4266,303,3865,739,4366,003,3086,198,3266,085,3506,078,4646,324,4796,599,4407,349,4167,788,0498,969,3719,829,02511,363,16211,363,16211,667,89213,979,80811,089,7939,219,948
Net income
-211k
L
216,298114,69795,28495,385163,608104,05429,015124,135120,66246,655-431,22352,878161,080298,088421,264421,264591,0162,642,997574,550-210,683
CFO
493k
-74.51%
386,495428,109234,899512,241327,300433,208270,597183,390290,365486,321797,072515,956987,4641,294,3891,523,7921,523,7921,676,0784,975,6341,933,280492,814
Dividend
Dec 02, 20220.005 CAD/sh

Profile

WestBond Enterprises Corporation, together with its subsidiary WestBond Industries Inc., manufactures and sells disposable paper products for medical, hygienic, and industrial uses in Canada and the United States. The company offers personal hygiene paper products, such as roll and folded hand towels, jumbo roll and conventional bathroom tissue, coreless tissue, center feed towels, and air-laid center feed towels; hospitality and tabletop paper products comprising air-laid napkins, guest towels, air-laid kitchen roll towels, and disposable bar towels; and clinical products, including sheets, examination table papers, waterproof sheets, pillowcases, examination drapes and gowns, and ultrasound towels and wipers. It also provides long-term care products, including fold and roll air laid patient wipes and waterproof underlays; disinfectant wipes and sprays; and airlaid rolls for converters. It sells its products primarily to medical and industrial distributors, as well as to end-users on a direct basis. WestBond Enterprises Corporation is headquartered in Delta, Canada.
IPO date
Feb 11, 1992
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
9,220
-16.86%
11,090
-20.67%
Cost of revenue
9,368
10,089
Unusual Expense (Income)
NOPBT
(148)
1,001
NOPBT Margin
9.02%
Operating Taxes
(91)
262
Tax Rate
26.13%
NOPAT
(58)
739
Net income
(211)
-136.67%
575
-78.26%
Dividends
(534)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
952
574
Long-term debt
3,307
3,853
Deferred revenue
Other long-term liabilities
Net debt
4,148
4,354
Cash flow
Cash from operating activities
493
1,933
CAPEX
(410)
(432)
Cash from investing activities
(410)
(432)
Cash from financing activities
(45)
(1,696)
FCF
636
955
Balance
Cash
111
73
Long term investments
Excess cash
Stockholders' equity
7,294
7,520
Invested Capital
10,085
10,200
ROIC
6.89%
ROCE
8.18%
EV
Common stock shares outstanding
35,626
35,626
Price
Market cap
EV
EBITDA
1,124
2,159
EV/EBITDA
Interest
147
143
Interest/NOPBT
14.24%